-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editorial || FREE PAPER ||
(1811) Views (398) Full article downloads
Authors: Garry Walsh
Published Date May 2005
Volume 2005:1(3) Pages 167 - 167
DOI: http://dx.doi.org/10.2147/TCRM.S
Garry Walsh
Asthmatic and Allergic Inflammation Group, School of Medicine, University of Aberdeen, UK
Welcome to the third issue of Therapeutics and Clinical Risk Management. As mentioned in my editorial to the first issue, the journal aims to publish original research and review articles on the evidence and opinion behind new and existing therapies. Thus, the remit of Therapeutics and Clinical Risk Management will of necessity be a broad one, and this issue vividly illustrates this.
Readers of this article also read:
Management of epilepsy in the elderly
Risk factors of allergic rhinitis: genetic or environmental?
Adverse drug reaction reporting in New Zealand: implications for pharmacists
The challenge of patient adherence
Inhibitors of selectin functions in the treatment of inflammatory skin disorders
Influence of anatomical site and topical formulation on skin penetration of sunscreens
Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia
Editorial ||FREE PAPER||
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
